Pure Global AI
CDSCO UID MFG/IVD/2019/000026_b621e532c7d5de75ba66f799e28c1cc0_62f3098208d039c76b53e590f025e4ef

Diagnostic tests/Reagents/kits for monitoring Buprenorphine drug levels used for therapy or abuse

Nucleus Diagnosys LLPDevice Class Class CIndia CDSCO
VerifiedCDSCO · official registry
Registration details
UID
MFG/IVD/2019/000026_b621e532c7d5de75ba66f799e28c1cc0_62f3098208d039c76b53e590f025e4ef
Device class
Class C
Approving authority
Central Drug Standards Control Organization, Ahmedabad
Product information
Buprenorphine ##PLACEHOLDER_0## test reagent/kits are the medical devices intended for the estimation of Buprenorphine ##PLACEHOLDER_0## and its metabolites in serum/body fluids
About this record

Diagnostic tests/Reagents/kits for monitoring Buprenorphine drug levels used for therapy or abuse is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2019/000026_b621e532c7d5de75ba66f799e28c1cc0_62f3098208d039c76b53e590f025e4ef. The license holder is Nucleus Diagnosys LLP, and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, Ahmedabad.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.